Palisade Bio (NASDAQ: PALI) Adds Pharmaceutical Industry Executive Robert McRae to Leadership Team
Expands Clinical Operations Team in Advance of Pivotal Clinical Studies CARLSBAD, Calif., Feb. 15, 2022…
Month: February 2022
Monopar Announces Clinical and Preclinical Program Updates
Validive Phase 2b/3 VOICE trial now open at 43 sites; active and enrolling in US…
Propella Therapeutics Presents Non-Clinical Data on PRL-02 at 2022 ASCO Genitourinary (GU) Cancers Symposium
Highlights Potential of PRL-02 as Best-in-Class, Next-Generation Androgen Biosynthesis Inhibitor for Treatment of Advanced Prostate…
Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases
Symptoms of mitochondrial diseases, such as Thymidine Kinase 2 deficiency (TK2d), can vary widely and…
PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer
The study evaluates PDS0101 with and without KEYTRUDA® prior to surgery for HPV-associated oropharyngeal cancer…
Hepion Pharmaceuticals Appoints World-Renowned Hepatologist, Dr. Eddie C. Cheung, to Lead the Company’s Strategic Medical Affairs in Asia
– Dr. Cheung, who has dedicated his career to NASH, hepatocellular carcinoma, fatty liver disease,…
Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com
SmallCapVoice.com Interview with Stella Diagnostics Inc. SmallCapVoice.com Inc. (“SCV”) announces the availability of a new…
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
Leading biopharma executive Brian Wiley joins as Chief Business Officer Experienced financial consultant Joseph Ciaverella…
Amarin to Report Fourth Quarter and Full Year 2021 Financial Results And Host Conference Call on March 1, 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
Cue Biopharma’s Therapeutic Immuno-STAT Biologics to be Featured in Oxford University Presentation at the Biophysical Society 2022 Annual Meeting
Presentation provides mechanistic insights and progress update on collaboration with the laboratory of Michael Dustin…
Marrone Bio and Corteva Agriscience Announce New Distribution Contract
The companies build on existing seed treatment partnership to offer novel foliar bionutrient GENEVA and…
InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer
Collaboration combines Intellia’s genome editing platform with ONK’s optimized natural killer (NK) cell therapy platform…
Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data Selected for Presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium
WORCESTER, Mass., Feb. 15, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
AVIPure® affinity resins address the market need for high performance and caustic stability WALTHAM, Mass.,…
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule…
Opus Genetics Appoints Brian Leising Vice President, Manufacturing
20-year biopharma industry veteran to lead manufacturing for Opus’ AAV-based gene therapies for inherited retinal…
Theratechnologies Strengthens Global Commercial Capabilities by Launching Internal Field Force
– Top Performing U.S. Based Key Account Managers, Medical Sales Liaisons, and Community Liaisons to…
Ocugen/Harris Poll Finds Americans Want More COVID-19 Vaccine Options
73% of Americans would like to see additional COVID-19 vaccines be available that are developed…